Navigation Links
Spherix Holds Annual Shareholders Meeting
Date:5/14/2008

BETHESDA, Md., May 14 /PRNewswire-FirstCall/ -- At their 2008 Annual Meeting, shareholders of Spherix Incorporated (Nasdaq: SPEX) elected the following members to the Board of Directors:

-- Douglas T. Brown, Senior VP and Manager of Corporate Banking Government

Contracting, PNC Bank

-- A. Paul Cox, Jr., Principal, Asset Protection Company

-- Claire L. Kruger, Chief Executive Officer and Chief Operating Officer,

Spherix

-- Gilbert V. Levin, Ph.D., Director of Science and Technology, Spherix

-- Robert A. Lodder, Jr., President, Spherix; and Professor, College of

Pharmacy, University of Kentucky

-- Aris Melissaratos, Senior Advisor to the President of Johns Hopkins

University

-- Robert J. Vander Zanden, Ph.D., former Vice President, R&D, Kraft Foods

International

In addition, Grant Thornton LLP was ratified as the Company's independent accountants for the year 2008.

Claire Kruger told the shareholders that Spherix management is focused and will continue to focus on the path forward necessary to bring Naturlose to market as a drug to treat Type 2 diabetes. To this end, three crucial activities are being undertaken in parallel:

1) Optimizing the efficiency and effectiveness of the clinical trial

program;

2) Evaluating the diabetes drug market potential to determine opportunity

and provide a clear understanding of our potential value;

3) Assuring supplies of tagatose, both the cGMP batches needed for the NDA

as well as a supplier to hold the Drug Master File once FDA approval

has been achieved.

At a Board of Directors meeting later the same day, the following slate of Corporate Officers was elected:

-- Paul Cox, Chairman of the Board

-- Claire Kruger, Chief Executive Officer and Chief Operating Officer

-- Robert Lodder, President

-- Robert Clayton, Interim Chief Financial Officer and Treasurer

-- Katherine Brailer, Corporate Secretary and Director of Administrative

Services

Certain statements contained herein are "forward looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied. Factors that could cause actual results to differ materially from those expressed or implied include, but are not limited to, those discussed in filings by the Company with the Securities and Exchange Commission, including the filing on Form 8-K made on October 10, 2007.

Spherix's mission is to create value and increase shareholder wealth through innovations that benefit our clients and the human condition. Spherix offers innovations in biotechnology, and provides technical and regulatory consulting services to biotechnology and pharmaceutical companies.

Spherix's Internet address is http://www.spherix.com.


'/>"/>
SOURCE Spherix Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Hires Key Employees
2. Spherix Reports 2007 Financial Results
3. Spherix Reports 3rd Quarter Earnings
4. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
5. Sinovac Biotech Holds Annual General Meeting
6. New Robotic Imaging Technology Holds Promise of Improved Cancer Care
7. Vion Pharmaceuticals Holds Special Meeting of Stockholders
8. Kiwa Bio-Tech Products Group Holds Meetings to Build Distribution Network
9. Kiwa Holds 2007 Annual Management Meetings and Employee Recognition Ceremonies in Beijing
10. Society for Biological Engineering Holds First International Conference on Stem Cell Engineering
11. CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... , ... May 31, 2016 , ... ... markets molecular imaging systems, today announced that their compact PET scanner called ... Imaging) has been selected by the University of Arizona (UA). , PET and ...
(Date:5/27/2016)... ... 2016 , ... NeuMedics Inc. is pleased to announce that CEO Iain Duncan ... June 2, 2016. The session begins at 1:10 PM and Iain will present the ... used as a topical agent and a treatment for ophthalmic complications of diabetes. , ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... PBI-Gordon Corporation ... Turf and Ornamental Products. , In his 15-year career with PBI-Gordon, Dave has served ... Manager, where he was integral in the development and launch of many of PBI-Gordon’s ...
(Date:5/27/2016)... and READING, England ... Indegene ( http://www.indegene.com ), ein führender ... für die Life-Science-Branche, Pharmaunternehmen und Gesundheitsorganisationen, und ... Anbieter von innovativen wissenschaftlichen Support-Services für den ... von IntraScience heute den Ausbau ihrer bestehenden ...
Breaking Biology Technology:
(Date:3/15/2016)... ALBANY, New York , March 15, 2016 ... a new market report published by Transparency Market Research "Digital ... Growth, Trends and Forecast 2015 - 2023," the global digital ... at US$ 731.9 Mn in 2014 and is forecast to ... to 2023. Growth of micro, small and medium enterprises (MSMEs) ...
(Date:3/11/2016)... http://www.apimages.com ) - --> http://www.apimages.com ) - ... ( http://www.apimages.com ) - Germany . The ... refugee identity cards. DERMALOG will be unveiling this device, and a ... next week.   --> Germany . ... new refugee identity cards. DERMALOG will be unveiling this device, and ...
(Date:3/9/2016)... 2016 This BCC Research report provides an ... RNA Sequencing (RNA Seq) market for the years 2015, ... and reagents, data analysis, and services. Use ... RNA-Sequencing market such as RNA-Sequencing tools and reagents, RNA-Sequencing ... affecting each segment and forecast their market growth, future ...
Breaking Biology News(10 mins):